Status:
COMPLETED
Short-term Outcomes of Elective High-risk PCI With Extracorporeal Membrane Oxygenation Support: a Single-centre Registry
Lead Sponsor:
Robert Jan van Geuns
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
Brief Summary
Background Revascularization of complex coronary artery disease, including multivessel coronary artery disease, left main stenosis, bifurcation stenosis and chronic total occlusions (CTO) can be perfo...
Eligibility Criteria
Inclusion
- Patients older than 18 years, who underwent high-risk PCI with VA-ECMO support.
- The use of mechanical circulatory support (MCS) is indicated by HeartTeam based on patient and lesion characteristics described in the expert consensus on the use of MCS Devices for high-risk PCI.
Exclusion
- \- Non-elective PCI with VA-ECMO support, primarily applied for cardiogenic shock or ECPR.
Key Trial Info
Start Date :
February 3 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 22 2022
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT05387902
Start Date
February 3 2022
End Date
March 22 2022
Last Update
May 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboud University Medical Centre
Nijmegen, Netherlands